However, in HGG, co-expression of IL-13Rα2 and nuclear and cytoplasmic FUS was correlated with worse OS, which suggested that the combination of these two markers might be a more precise approach to predict glioma progression. This evidence concerns the gene FUS and central nervous system cancer.